EMERGENT BIOSOLUTIONS INC. (EBS) Gross margin 2020–2023
EMERGENT BIOSOLUTIONS INC. (EBS) gross margin by fiscal year — reported gross profit divided by reported revenue.
30.3%FY2023 · since FY2020: 59.5% → 30.3%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2023 | 30.3% | -4.0 pp |
| FY2022 | 34.3% | -16.0 pp |
| FY2021 | 50.3% | -9.2 pp |
| FY2020 | 59.5% | — |
Gross margin = reported gross profit ÷ reported revenue for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice